LG
THC icon

Leuthold Group’s Tenet Healthcare THC Stock Holding History

Leuthold Group’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.93M Sell
31,675
-1,552
-5% -$285K 0.6% 64
2026
Q1 		$6.27M Buy
33,227
+443
+1% +$93.3K 0.67% 52
2025
Q4 		$6.51M Buy
32,784
+2,912
+10% +$588K 0.7% 51
2025
Q3 		$6.07M Buy
29,872
+1,015
+4% +$180K 0.66% 57
2025
Q2 		$5.08M Sell
28,857
-3,910
-12% -$589K 0.61% 60
2025
Q1 		$4.41M Sell
32,767
-2,192
-6% -$289K 0.57% 61
2024
Q4 		$4.41M Sell
34,959
-1,128
-3% -$168K 0.53% 74
2024
Q3 		$6M Sell
36,087
-128
-0.4% -$19.4K 0.67% 59
2024
Q2 		$4.82M Buy
36,215
+2,670
+8% +$321K 0.56% 66
2024
Q1 		$3.53M Sell
33,545
-16
-0% -$1.44K 0.4% 100
2023
Q4 		$2.54M Sell
33,561
-73
-0.2% -$4.63K 0.32% 108
2023
Q3 		$2.22M Buy
+33,634
New +$2.51M 0.31% 109
2019
Q3 		– Sell
-90,235
Closed -$1.86M – 208
2019
Q2 		$1.86M Sell
90,235
-5,661
-6% -$130K 0.24% 121
2019
Q1 		$2.77M Sell
95,896
-3,024
-3% -$74.7K 0.37% 97
2018
Q4 		$1.7M Sell
98,920
-11,460
-10% -$277K 0.24% 121
2018
Q3 		$3.14M Buy
+110,380
New +$3.64M 0.34% 112

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Leuthold Group's THC Position: Q2 2026 in Review

Leuthold Group reduced its Tenet Healthcare (THC) stake by 4.7% in Q2 2026, selling an estimated $285K and leaving 31,675 shares worth $5.93M. The position accounts for 0.6% of the portfolio, ranked #64.

Leuthold Group first reported a position in THC in Q3 2018 and has held it in 16 quarters since. The position peaked at $6.51M in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Leuthold Group held 31,675 shares of Tenet Healthcare worth $5.93M as of Q2 2026.
  • Leuthold Group sold 1,552 Tenet Healthcare shares in Q2 2026, an estimated $285K.
  • Tenet Healthcare made up 0.6% of Leuthold Group's portfolio in Q2 2026, its #64 holding.
  • Leuthold Group first reported a position in Tenet Healthcare in Q3 2018 and has held it in 16 quarters since.
  • Leuthold Group's Tenet Healthcare position peaked at $6.51M in Q4 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Leuthold Group's 13F filing for Q2 2026, filed 4 Aug 2026.